5-Bromo-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, 95+%, 1g

2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one, 97.0%, 250g

1-(3-chloro-2-pyridinyl)piperazine, 95.0%, 10g

Colonne capillaire GC ROTI®Cap-WAX, 25 m, 0,32 mm, 0,25 µm, 1 pièce(s)

4-Methyl-1-phenyl-2-pentanol, 96.0%, 25g

1-METHYL-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXYLIC ACID, 95.0%, 1g

2-(Methoxycarbonyl)nicotinic acid, 97.0%, 1g

2,2'-(Propane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 100mg

5-(2-Bromo-4-(trifluoromethoxy)phenyl)oxazole, 98%, 500mg

4-Isobutoxybenzaldehyde, 97.0%, 10g

4-(5-Cyanofuran-2-yl)benzoic acid, 97%, 100mg

4-(4-Methylpiperazinyl)benzaldehyde>98.0%(GC)(T)5g

2-(2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}ethoxy)acetic acid, 97.0%, 25g